CAS: 1229453-99-9 - Acrizanib
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Acrizanib REF: AN-AG01FPMBCAS: 1229453-99-9 | 98% | To inquire | Tue 21 May 24 |
 | Acrizanib REF: TM-T5373CAS: 1229453-99-9 | 98.72% | 127.00 €~1,468.00 € | Tue 21 May 24 |
 | Acrizanib REF: 54-BISN0088CAS: 1229453-99-9 | 99% | 424.00 €~1,159.00 € | Tue 28 May 24 |
 | Acrizanib (LHA510) REF: 3D-EZB45399CAS: 1229453-99-9 | Min. 95% | To inquire | Tue 02 Jul 24 |
Ref: AN-AG01FPMB
| 1mg | 225.00 € | |
| 2mg | 325.00 € | |
| 5mg | 484.00 € | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Tuesday 21 May 2024
Acrizanib
CAS:1229453-99-9
Acrizanib (LHA510) is a VEGFR-2 inhibitor, with an IC50 of 17.4 nM for BaF3-VEGFR-2.
Formula:
C20H18F3N7O2
Purity:
98.72%
Color and Shape:
Solid
Molecular weight:
445.4
Ref: TM-T5373
| 1mg | 127.00 € | |
| 2mg | 182.00 € | |
| 5mg | 305.00 € | |
| 10mg | 491.00 € | |
| 25mg | 798.00 € | |
| 50mg | 1,106.00 € | |
| 100mg | 1,468.00 € | |
| 1ml*10 (DMSO) | 338.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
Ref: 54-BISN0088
| 1mg | 424.00 € | |
| 5mg | 715.00 € | |
| 10mg | 1,159.00 € |
Estimated delivery in United States, on Tuesday 28 May 2024
Acrizanib (LHA510)
CAS:1229453-99-9
Acrizanib is a tyrosine kinase inhibitor that has been shown to reduce the growth of …
Formula:
C20H18F3N7O2
Purity:
Min. 95%
Molecular weight:
445.4 g/mol
Ref: 3D-EZB45399
| 1mg | To inquire | |
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 2 Jul 2024
